JW
Therapeutic Areas
Neurotez Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Leptin-based therapy | Alzheimer's Disease (Treatment and Prevention) | Pre-clinical |
Leadership Team at Neurotez
NT
Nikolaos Tezapsidis, PhD
Founder, President, CEO, Chairman
JK
Jukka Karjalainen, MD, PhD
Chief Operating Officer
HM
Hamish McArthur, PhD
Manufacturing Chief Officer
JM
Jane M. Johnston, PhD
Vice President of Operations
JH
James Harris, MBA
Acting CFO, Director